Skip to content

Investigating the effect of probiotics in gastroenteritis

Investigating the effect of Kidi Lact probiotic supplement administration on the symptoms of diarrhea and dehydration caused by gastroenteritis in children

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241029063537N1
Enrollment
400
Registered
2025-01-14
Start date
2025-03-21
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroenteritis. Viral and other specified intestinal infections

Interventions

Intervention 1: Intervention group: Kidi Lact Sachet is an unflavored edible sachet containing safe and beneficial bacterial strains and prebiotic fructooligosaccharide (FOS). The company that manufac

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Months to 72 Months

Inclusion criteria

Inclusion criteria: Consent to participate in a research project Suffering from acute gastroenteritis and signs and symptoms of acute non-bloody diarrhea, and mild to moderate dehydration that have an indication for liquid therapy Refer to the medical center within the first 72 hours from the onset of symptoms.

Exclusion criteria

Exclusion criteria: Unwillingness to participate in a research project Gastroenteritis patients who are more than 6 years old and less than one year old Children who have been sick for more than 72 hours Children with chronic gastrointestinal disease (such as inflammatory bowel disease and Celiac disease), severe malnutrition (grade 2 and 3), pancreatic insufficiency Children with underlying diseases such as allergy to probiotic products Children with kidney failure, chronic lung diseases, congenital heart failure and clear neurological disease Children who receive antibiotics or acid-blocking drugs or who have taken probiotics for any reason within a week before entering the study. Change in treatment due to new diagnosis, treatment in the form of receiving serum in medical centers before going to Amir--al-Momenin Hospital The existence of unexplained abnormal findings in the urine sample

Design outcomes

Primary

MeasureTime frame
Severity of dehydration. Timepoint: The beginning and end of the study. Method of measurement: Urine test (BUN, Creatinine,and urine specific gravity); blood test (sodium and potassium); clinical symptoms (nurse's report and child's mother's report).

Secondary

MeasureTime frame
Frequency of diarrhea. Timepoint: The beginning and end of the study. Method of measurement: The report of the nurse and the report of the child's mother.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHouman Parsaie

Semnan University of Medical Sciences

houman70parsaie@semums.ac.ir+98 23 3365 4162

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026